- Home
- APVO vs TOMZ Comparison
APVO vs TOMZ Comparison
Compare APVO & TOMZ Stocks: Price Trends, ML Decisions, Charts, Trends, Technical Analysis and more.
- Machine Learning Prediction
- ML Decision
- APVO
- TOMZ
- Stock Information
- Founded
- APVO 2016
- TOMZ 1979
- Country
- APVO United States
- TOMZ United States
- Employees
- APVO N/A
- TOMZ N/A
- Industry
- APVO Biotechnology: Pharmaceutical Preparations
- TOMZ Diversified Commercial Services
- Sector
- APVO Health Care
- TOMZ Finance
- Exchange
- APVO Nasdaq
- TOMZ Nasdaq
- Market Cap
- APVO 21.7M
- TOMZ 20.3M
- IPO Year
- APVO N/A
- TOMZ N/A
- Fundamental
- Price
- APVO $1.46
- TOMZ $0.91
- Analyst Decision
- APVO
- TOMZ Strong Buy
- Analyst Count
- APVO 0
- TOMZ 1
- Target Price
- APVO N/A
- TOMZ $3.50
- AVG Volume (30 Days)
- APVO 4.5M
- TOMZ 25.7K
- Earning Date
- APVO 11-10-2025
- TOMZ 11-07-2025
- Dividend Yield
- APVO N/A
- TOMZ N/A
- EPS Growth
- APVO N/A
- TOMZ N/A
- EPS
- APVO N/A
- TOMZ N/A
- Revenue
- APVO N/A
- TOMZ $6,219,036.00
- Revenue This Year
- APVO N/A
- TOMZ $18.31
- Revenue Next Year
- APVO N/A
- TOMZ $103.30
- P/E Ratio
- APVO N/A
- TOMZ N/A
- Revenue Growth
- APVO N/A
- TOMZ N/A
- 52 Week Low
- APVO $1.32
- TOMZ $0.63
- 52 Week High
- APVO $298.00
- TOMZ $1.50
- Technical
- Relative Strength Index (RSI)
- APVO 42.13
- TOMZ 43.78
- Support Level
- APVO $1.48
- TOMZ $0.89
- Resistance Level
- APVO $1.57
- TOMZ $0.96
- Average True Range (ATR)
- APVO 0.09
- TOMZ 0.04
- MACD
- APVO 0.00
- TOMZ -0.01
- Stochastic Oscillator
- APVO 0.00
- TOMZ 21.50
About APVO Aptevo Therapeutics Inc.
Aptevo Therapeutics Inc is a clinical-stage research and development biotechnology company focused on developing novel immunotherapeutic candidates for the treatment of different forms of cancer. Its clinical candidates are; ALG.APV-527, which targets co-stimulatory receptors and tumor antigens, and CD3xCD123, which is being developed as a potential treatment of frontline acute myelogenous leukemia. The company's preclinical candidates, APVO711, APVO0442, and APVO603, are being developed using the ADAPTIR modular protein technology platform. The company's versatile and robust ADAPTIR and ADAPTIR-FLEX platforms are designed to generate monospecific, bispecific, and multi-specific antibody candidates that are capable of enhancing the human immune system against cancer cells.
About TOMZ TOMI Environmental Solutions Inc.
TOMI Environmental Solutions Inc is a leader in bacteria decontamination and infectious disease control, offering environmentally friendly solutions for indoor air and surface disinfection and decontamination. Its flagship product, SteraMist, uses patented and registered Binary Ionization Technology (BIT) to deliver a low-percentage (7.8%) hydrogen peroxide-based fog or mist to affect all indoor environments and surface areas. Its product portfolio includes The SteraPak, The Surface Unit, The Transport, The NV+, The Environment System, SteraMist Integrated System, BIT Solution, and Custom Engineered System.